Skip to main content
Clinical Trials/JPRN-UMIN000009040
JPRN-UMIN000009040
Completed
未知

A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients with moderate to severe disease activities and healthy adults - A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients

Chugai Pharmaceutical co., ltd.0 sites110 target enrollmentOctober 4, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Systemic lupus erythematosus
Sponsor
Chugai Pharmaceutical co., ltd.
Enrollment
110
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (ERL/LN) \-Unstable neuropsychiatric SLE at the time of sampling. \-Evidence of significant uncontrolled concomitant diseases (e.g., cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disorders) at the time of sampling. \-Conditions other than SLE that could require treatment with corticosteroids (e.g., asthma) at the time of within 12 months prior to sampling. \-History of cancer within 5 years prior to sampling. \-History of congenital immunodeficiency. \-Signs or symptoms of infection within 31 days prior to sampling (Healthy adults) \-Evidence of concomitant diseases (e.g., cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disorders) at the time of sampling. \-History of cancer within 5 years prior to sampling. \-Any clinically abnormal conditions at the time of sampling. \-Signs or symptoms of infection within 31 days prior to sampling.

Outcomes

Primary Outcomes

Not specified

Similar Trials